These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1054 related items for PubMed ID: 8473395

  • 1. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR, Aceto T, Weber C, Pang S.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [Abstract] [Full Text] [Related]

  • 2. The pattern of gonadotropin and estradiol secretion in exaggerated thelarche.
    Garibaldi LR, Aceto T, Weber C.
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):345-50. PubMed ID: 8498153
    [Abstract] [Full Text] [Related]

  • 3. Central precocious puberty: a single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment.
    Salerno M, Di Maio S, Gasparini N, Mariano A, Macchia V, Tenore A.
    Horm Res; 1998 Apr; 50(4):205-11. PubMed ID: 9838241
    [Abstract] [Full Text] [Related]

  • 4. Effect of gonadotropin-releasing hormone analog on ovarian reserve in children with central precocious puberty.
    Tao Y, Si C, Li H, Han J, Hou H, Yang M.
    Ann Palliat Med; 2020 Jan; 9(1):53-62. PubMed ID: 32005063
    [Abstract] [Full Text] [Related]

  • 5. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP, Jones JV, Barnes K, Oerter-Klein K, Cutler GB.
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of basal LH in monitoring central precocious puberty treatment in girls.
    Calcaterra V, De Filippo G, Albertini R, Rendina D, Messini B, Monti CM, Bozzola E, Villani A, Bozzola M.
    J Pediatr Endocrinol Metab; 2021 Jan 27; 34(1):45-50. PubMed ID: 33189082
    [Abstract] [Full Text] [Related]

  • 7. Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty.
    Neely EK, Wilson DM, Lee PA, Stene M, Hintz RL.
    J Pediatr; 1995 Jul 27; 127(1):47-52. PubMed ID: 7608810
    [Abstract] [Full Text] [Related]

  • 8. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone.
    Pescovitz OH, Hench KD, Barnes KM, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1988 Sep 27; 67(3):474-9. PubMed ID: 3137242
    [Abstract] [Full Text] [Related]

  • 9. Gonadotropin-releasing hormone testing in premature thelarche.
    Choubtum L, Mahachoklertwattana P, Sriphrapradang A, Preeyasombat C.
    J Med Assoc Thai; 1999 Nov 27; 82 Suppl 1():S33-8. PubMed ID: 10730515
    [Abstract] [Full Text] [Related]

  • 10. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
    Neely EK, Hintz RL, Parker B, Bachrach LK, Cohen P, Olney R, Wilson DM.
    J Pediatr; 1992 Oct 27; 121(4):634-40. PubMed ID: 1403402
    [Abstract] [Full Text] [Related]

  • 11. Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test.
    Ibáñez L, Potau N, Zampolli M, Virdis R, Gussinyé M, Carrascosa A, Saenger P, Vicens-Calvet E.
    J Clin Endocrinol Metab; 1994 Jan 27; 78(1):30-5. PubMed ID: 7507123
    [Abstract] [Full Text] [Related]

  • 12. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
    Sklar CA, Rothenberg S, Blumberg D, Oberfield SE, Levine LS, David R.
    J Clin Endocrinol Metab; 1991 Oct 27; 73(4):734-8. PubMed ID: 1909701
    [Abstract] [Full Text] [Related]

  • 13. Inhibin B, follicle stimulating hormone, luteinizing hormone, and estradiol and their relationship to the regulation of follicle development in girls during childhood and puberty.
    Chada M, Průsa R, Bronský J, Pechová M, Kotaska K, Lisá L.
    Physiol Res; 2003 Oct 27; 52(3):341-6. PubMed ID: 12790766
    [Abstract] [Full Text] [Related]

  • 14. Assessment of Gonadotropin Concentrations Stimulated by Gonadotropin-Releasing Hormone Analog by Electrochemiluminescence in Girls with Precocious Puberty and Premature Thelarche.
    de Souza KBF, Veiga MSP, Martins GRF, da Silva AP, Fujita LGA, Tomé JM, Palhares HMDC, Borges MF.
    Horm Res Paediatr; 2021 Oct 27; 94(11-12):433-440. PubMed ID: 34933304
    [Abstract] [Full Text] [Related]

  • 15. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF, Crawford JD, Crowley WF.
    Endocr Rev; 1986 Feb 27; 7(1):24-33. PubMed ID: 2937629
    [Abstract] [Full Text] [Related]

  • 16. The Use of Morning Urinary Gonadotropins and Sex Hormones in the Management of Early Puberty in Chinese Girls.
    Zhan S, Huang K, Wu W, Zhang D, Liu A, Dorazio RM, Shi J, Ullah R, Zhang L, Wang J, Dong G, Ni Y, Fu J.
    J Clin Endocrinol Metab; 2021 Oct 21; 106(11):e4520-e4530. PubMed ID: 34160619
    [Abstract] [Full Text] [Related]

  • 17. The histrelin implant: a novel treatment for central precocious puberty.
    Hirsch HJ, Gillis D, Strich D, Chertin B, Farkas A, Lindenberg T, Gelber H, Spitz IM.
    Pediatrics; 2005 Dec 21; 116(6):e798-802. PubMed ID: 16322137
    [Abstract] [Full Text] [Related]

  • 18. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
    Brito VN, Latronico AC, Arnhold IJ, Mendonca BB.
    J Clin Endocrinol Metab; 2004 Sep 21; 89(9):4338-42. PubMed ID: 15356030
    [Abstract] [Full Text] [Related]

  • 19. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins.
    Apter D, Bützow TL, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1993 Apr 21; 76(4):940-9. PubMed ID: 8473410
    [Abstract] [Full Text] [Related]

  • 20. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C.
    J Clin Endocrinol Metab; 1988 Feb 21; 66(2):327-33. PubMed ID: 3123511
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 53.